Your browser doesn't support javascript.
loading
Parkinson's Disease: Alpha Synuclein, Heme Oxygenase and Biotherapeutic Countermeasures.
Haines, David D; Trushin, Maxim V; Rose, Stephen; Bernard, Iloki Assanga Simon; Mahmoud, Fadia F.
Afiliação
  • Haines DD; Northwell Health System, New York, NY, United States.
  • Trushin MV; Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russian Federation.
  • Rose S; Bioengineering and Nanotechnology MA Program, Harvard University, Cambridge, Massachusetts, 01254, United States.
  • Bernard IAS; Department of Biological Sciences, Universidad de Sonora, Blvd. Luis Encinas y Rosales, Hermosillo, Sonora, Mexico.
  • Mahmoud FF; Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Kuwait University, Kuwait.
Curr Pharm Des ; 24(20): 2317-2321, 2018.
Article em En | MEDLINE | ID: mdl-30019639
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Alfa-Sinucleína / Heme Oxigenase (Desciclizante) / Antiparkinsonianos Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Alfa-Sinucleína / Heme Oxigenase (Desciclizante) / Antiparkinsonianos Idioma: En Ano de publicação: 2018 Tipo de documento: Article